Hartman William R, Hess Aaron S, Connor Joseph P
Department of Anesthesiology, University of Wisconsin-Madison School of Medicine and Public Health, USA.
Department Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, USA.
Case Rep Cardiol. 2020 Oct 2;2020:8863195. doi: 10.1155/2020/8863195. eCollection 2020.
COVID-19 infection caused by the SARS-CoV-2 virus has been associated with cardiac abnormalities, including conduction abnormalities. Convalescent plasma is emerging as a potentially safe and effective treatment option for patients severely or critically ill with COVID-19. Here, we describe a case of a COVID-19 patient with new-onset cardiac ectopy who had near resolution of his cardiac sequelae following convalescent plasma transfusion.
由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒引起的2019冠状病毒病（COVID-19）感染与心脏异常有关，包括传导异常。康复期血浆正在成为治疗重症或危重症COVID-19患者的一种潜在安全有效的治疗选择。在此，我们描述了一例COVID-19患者，该患者出现新发心脏异位，在接受康复期血浆输注后心脏后遗症几乎消失。
